Normal Gastrointestinal Stool Testing Market Global Research Report 2019

GI Stool Testing Market 2015-2019 – Global Market Research is a new research report added by under the diagnostics category. The report also includes a discussion on the key vendors operating in this market.

The global GI stool testing market is expected to grow at a CAGR of 7.37% during 2014-2019. Normal gastrointestinal (GI) functioning is essential for digestion as well as for the removal of body waste and pathogens. GI disorders are a common problem in the general population. These disorders are known to cause severe harm to the health and quality of life of an individual. These disorders include malabsorption disorders, inflammatory bowel diseases, cancer of the digestive system, colitis, and gastroenteritis. Globally, about 1.7-2 billion cases of diarrheal diseases occur every year. Also, about 1,700 million cases of C. difficile infections have been reported worldwide every year.

Stool tests are used for the diagnosis of GI disorders and help detect parasite infection, inflammation, bleeding obstruction, and tumors in the GI tract and digestive system. The diagnosis of GI diseases is commonly done through laboratory tests using antigen or culture detection from stool samples. A stool test is of two categories: fecal occult blood test (FOBT) and clinical microbiological stool tests.

These tests are either antibody-based or microbial particle-based detection methods, which include immunoassay, CLIA, and molecular diagnostic testing. Stool tests are used for the screening of colorectal cancer as well as the detection of pathogens such as C. difficile, H. pylora, Rotavirus, and Adenovirus.

Inquire for more information @

Single User License USD 2500

Covered in this report

This report covers the present scenario and growth prospects of the global GI stool testing market for 2015-2019. To calculate the market size, we consider revenue generated from the sales of the following products:

  • FOBT
  • Clinical microbiology stool test

The report, Global GI Stool Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape of the global BI and analytics platform market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • Clinical Genomics
  • Diasorin
  • Meridian Bioscience
  • Quidel

Other prominent vendors

  • Alere
  • Beckman Coulter
  • bioMérieux
  • Bio-Rad Laboratories
  • CARE Products
  • Cenogenics
  • Epigenomics
  • Epitope Diagnostic
  • Exact Sciences
  • Helena Laboratories
  • Hemosure
  • Mobidiag
  • Orion Diagnostica
  • Pinnacle BioLabs
  • Polymedco
  • Propper Manufacturing
  • ScheBo Biotech
  • Trinity Biotech

Key market driver

  • Increased incidence of C. difficile infections

Key market challenge

  • Accurate diagnostic testing

Key market trend

  • Focus on rapid and early diagnosis

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

About US: is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.